The Europe Protein Crystallization Market should witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The creation of new technology significantly impacts the need for protein crystallization. Moreover, the market for crystallization and crystallography will expand due to the growing demand for high-resolution data on protein structures. Increased government funding and R&D efforts in the pharmaceutical and biotechnology sectors, which necessitate the use of crystallization and crystallography methods, are further factors driving the growth of the protein crystallization market.
One of the main factors fueling the market's expansion is the rising need for protein therapies. This is due to protein therapies' recent integration into the healthcare sector. In addition, because of their low immunogenicity and specificity, protein therapies are widely employed to treat various severe disorders, including cancer. As a result, the manufacturers have adopted growth strategies to capture the largest market share, consequently accelerating the market's growth, in response to the rising demand for protein-based medications and treatments.
Pharmaceutical companies have been driven to provide effective medications to combat the growing number of cardiac problems due to the expanding disease burden prevalence. The governments in the area are also establishing regulations that will facilitate the production and approval of various pharmaceuticals. In 2018, Russia spent an average of $140 per person on prescription drugs. Pharmaceutical sales in Russia were over $20.1 billion in the same year, accounting for 1.2% of the country's GDP and 22.1% of its total health expenditures. The market for protein crystallization is expected to grow in Europe due to the rising healthcare and pharmaceutical industries there.
The Germany market dominated the Europe Protein Crystallization Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $117.6 million by 2028. The UK market is anticipated to grow at a CAGR of 6.8% during (2022-2028). Additionally, The France market would exhibit a CAGR of 8.6% during (2022-2028).
Based on End-user, the market is segmented into Pharmaceutical & BioProduct Companies and Academic & Research Institutes. Based on Technology, the market is segmented into X-ray Crystallography, Cryo-electron Microscopy, NMR Spectroscopy and Others. Based on Product, the market is segmented into Instruments, Consumables and Software & Services. Based on Instruments Type, the market is segmented into Liquid Handling Instruments and Crystal Imaging Instruments. Based on Consumables Type, the market is segmented into Reagents & Kits/Screens, Micro Plates and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Corning Incorporated, Mettler-Toledo International, Inc., Greiner Bio-One International GmbH (Greiner AG), Rigaku Holdings Corporation, Formulatrix, Inc., Hampton Research Corp., Jena Bioscience GmbH, Creative Proteomics, and Molecular Dimentions Ltd (Anatrace Products LLC)
The creation of new technology significantly impacts the need for protein crystallization. Moreover, the market for crystallization and crystallography will expand due to the growing demand for high-resolution data on protein structures. Increased government funding and R&D efforts in the pharmaceutical and biotechnology sectors, which necessitate the use of crystallization and crystallography methods, are further factors driving the growth of the protein crystallization market.
One of the main factors fueling the market's expansion is the rising need for protein therapies. This is due to protein therapies' recent integration into the healthcare sector. In addition, because of their low immunogenicity and specificity, protein therapies are widely employed to treat various severe disorders, including cancer. As a result, the manufacturers have adopted growth strategies to capture the largest market share, consequently accelerating the market's growth, in response to the rising demand for protein-based medications and treatments.
Pharmaceutical companies have been driven to provide effective medications to combat the growing number of cardiac problems due to the expanding disease burden prevalence. The governments in the area are also establishing regulations that will facilitate the production and approval of various pharmaceuticals. In 2018, Russia spent an average of $140 per person on prescription drugs. Pharmaceutical sales in Russia were over $20.1 billion in the same year, accounting for 1.2% of the country's GDP and 22.1% of its total health expenditures. The market for protein crystallization is expected to grow in Europe due to the rising healthcare and pharmaceutical industries there.
The Germany market dominated the Europe Protein Crystallization Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $117.6 million by 2028. The UK market is anticipated to grow at a CAGR of 6.8% during (2022-2028). Additionally, The France market would exhibit a CAGR of 8.6% during (2022-2028).
Based on End-user, the market is segmented into Pharmaceutical & BioProduct Companies and Academic & Research Institutes. Based on Technology, the market is segmented into X-ray Crystallography, Cryo-electron Microscopy, NMR Spectroscopy and Others. Based on Product, the market is segmented into Instruments, Consumables and Software & Services. Based on Instruments Type, the market is segmented into Liquid Handling Instruments and Crystal Imaging Instruments. Based on Consumables Type, the market is segmented into Reagents & Kits/Screens, Micro Plates and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Corning Incorporated, Mettler-Toledo International, Inc., Greiner Bio-One International GmbH (Greiner AG), Rigaku Holdings Corporation, Formulatrix, Inc., Hampton Research Corp., Jena Bioscience GmbH, Creative Proteomics, and Molecular Dimentions Ltd (Anatrace Products LLC)
Scope of the Study
By End-user
- Pharmaceutical & BioProduct Companies
- Academic & Research Institutes
By Technology
- X-ray Crystallography
- Cryo-electron Microscopy
- NMR Spectroscopy
- Others
By Product
- Instruments
- Liquid Handling Instruments
- Crystal Imaging Instruments
- Consumables
- Reagents & Kits/Screens
- Micro Plates
- Others
- Software & Services
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Bruker Corporation
- Corning Incorporated
- Mettler-Toledo International, Inc.
- Greiner Bio-One International GmbH (Greiner AG)
- Rigaku Holdings Corporation
- Formulatrix, Inc.
- Hampton Research Corp.
- Jena Bioscience GmbH
- Creative Proteomics
- Molecular Dimentions Ltd (Anatrace Products LLC)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Protein Crystallization Market, by End User
1.4.2 Europe Protein Crystallization Market, by Technology
1.4.3 Europe Protein Crystallization Market, by Product
1.4.4 Europe Protein Crystallization Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Protein crystallization market
Chapter 4. Europe Protein Crystallization Market by End User
4.1 Europe Pharmaceutical & BioProduct Companies Market by Country
4.2 Europe Academic & Research Institutes Market by Country
Chapter 5. Europe Protein Crystallization Market by Technology
5.1 Europe X-ray Crystallography Market by Country
5.2 Europe Cryo-electron Microscopy Market by Country
5.3 Europe NMR Spectroscopy Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Protein Crystallization Market by Product
6.1 Europe Instruments Market by Country
6.2 Europe Protein Crystallization Market by Instruments Type
6.2.1 Europe Liquid Handling Instruments Market by Country
6.2.2 Europe Crystal Imaging Instruments Market by Country
6.3 Europe Consumables Market by Country
6.4 Europe Protein Crystallization Market by Consumables Type
6.4.1 Europe Reagents & Kits/Screens Market by Country
6.4.2 Europe Micro Plates Market by Country
6.4.3 Europe Others Market by Country
6.5 Europe Software & Services Market by Country
Chapter 7. Europe Protein Crystallization Market by Country
7.1 Germany Protein Crystallization Market
7.1.1 Germany Protein Crystallization Market by End User
7.1.2 Germany Protein Crystallization Market by Technology
7.1.3 Germany Protein Crystallization Market by Product
7.1.3.1 Germany Protein Crystallization Market by Instruments Type
7.1.3.2 Germany Protein Crystallization Market by Consumables Type
7.2 UK Protein Crystallization Market
7.2.1 UK Protein Crystallization Market by End User
7.2.2 UK Protein Crystallization Market by Technology
7.2.3 UK Protein Crystallization Market by Product
7.2.3.1 UK Protein Crystallization Market by Instruments Type
7.2.3.2 UK Protein Crystallization Market by Consumables Type
7.3 France Protein Crystallization Market
7.3.1 France Protein Crystallization Market by End User
7.3.2 France Protein Crystallization Market by Technology
7.3.3 France Protein Crystallization Market by Product
7.3.3.1 France Protein Crystallization Market by Instruments Type
7.3.3.2 France Protein Crystallization Market by Consumables Type
7.4 Russia Protein Crystallization Market
7.4.1 Russia Protein Crystallization Market by End User
7.4.2 Russia Protein Crystallization Market by Technology
7.4.3 Russia Protein Crystallization Market by Product
7.4.3.1 Russia Protein Crystallization Market by Instruments Type
7.4.3.2 Russia Protein Crystallization Market by Consumables Type
7.5 Spain Protein Crystallization Market
7.5.1 Spain Protein Crystallization Market by End User
7.5.2 Spain Protein Crystallization Market by Technology
7.5.3 Spain Protein Crystallization Market by Product
7.5.3.1 Spain Protein Crystallization Market by Instruments Type
7.5.3.2 Spain Protein Crystallization Market by Consumables Type
7.6 Italy Protein Crystallization Market
7.6.1 Italy Protein Crystallization Market by End User
7.6.2 Italy Protein Crystallization Market by Technology
7.6.3 Italy Protein Crystallization Market by Product
7.6.3.1 Italy Protein Crystallization Market by Instruments Type
7.6.3.2 Italy Protein Crystallization Market by Consumables Type
7.7 Rest of Europe Protein Crystallization Market
7.7.1 Rest of Europe Protein Crystallization Market by End User
7.7.2 Rest of Europe Protein Crystallization Market by Technology
7.7.3 Rest of Europe Protein Crystallization Market by Product
7.7.3.1 Rest of Europe Protein Crystallization Market by Instruments Type
7.7.3.2 Rest of Europe Protein Crystallization Market by Consumables Type
Chapter 8. Company Profiles
8.1 Bruker Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Corning Incorporated
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Mettler-Toledo International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Greiner Bio-One International GmbH (Greiner AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.5 Rigaku Holdings Corporation
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.5.2.2 Acquisition and Mergers:
8.5.2.3 Partnerships, Collaborations, and Agreements:
8.6 Formulatrix, Inc.
8.6.1 Company Overview
8.7 Hampton Research Corp.
8.7.1 Company Overview
8.8 Jena Bioscience GmbH
8.8.1 Company Overview
8.9 Creative Proteomics
8.9.1 Company Overview
8.10. Molecular Dimentions Ltd (Anatrace Products LLC)
8.10.1 Company Overview
Companies Mentioned
- Bruker Corporation
- Corning Incorporated
- Mettler-Toledo International, Inc.
- Greiner Bio-One International GmbH (Greiner AG)
- Rigaku Holdings Corporation
- Formulatrix, Inc.
- Hampton Research Corp.
- Jena Bioscience GmbH
- Creative Proteomics
- Molecular Dimentions Ltd (Anatrace Products LLC)
Methodology
LOADING...
